Diagnosis and treatment of Basal cell and squamous cell carcinoma - PubMed
- ️Sun Jan 01 2012
Review
. 2012 Jul 15;86(2):161-8.
Affiliations
- PMID: 22962928
Free article
Review
Diagnosis and treatment of Basal cell and squamous cell carcinoma
Jonathon M Firnhaber. Am Fam Physician. 2012.
Free article
Abstract
Family physicians are regularly faced with identifying, treating, and counseling patients with skin cancers. Nonmelanoma skin cancer, which encompasses basal cell and squamous cell carcinoma, is the most common cancer in the United States. Ultraviolet B exposure is a significant factor in the development of basal cell and squamous cell carcinoma. The use of tanning beds is associated with a 1.5-fold increase in the risk of basal cell carcinoma and a 2.5-fold increase in the risk of squamous cell carcinoma. Routine screening for skin cancer is controversial. The U.S. Preventive Services Task Force cites insufficient evidence to recommend for or against routine whole-body skin examination to screen for skin cancer. Basal cell carcinoma most commonly appears as a pearly white, dome-shaped papule with prominent telangiectatic surface vessels. Squamous cell carcinoma most commonly appears as a firm, smooth, or hyperkeratotic papule or plaque, often with central ulceration. Initial tissue sampling for diagnosis involves a shave technique if the lesion is raised, or a 2- to 4-mm punch biopsy of the most abnormal-appearing area of skin. Mohs micrographic surgery has the lowest recurrence rate among treatments, but is best considered for large, high-risk tumors. Smaller, lower-risk tumors may be treated with surgical excision, electrodesiccation and curettage, or cryotherapy. Topical imiquimod and fluorouracil are also potential, but less supported, treatments. Although there are no clear guidelines for follow-up after an index nonmelanoma skin cancer, monitoring for recurrence is prudent because the risk of subsequent skin cancer is 35 percent at three years and 50 percent at five years.
Similar articles
-
Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.
Firnhaber JM. Firnhaber JM. Am Fam Physician. 2020 Sep 15;102(6):339-346. Am Fam Physician. 2020. PMID: 32931212 Review.
-
Bahner JD, Bordeaux JS. Bahner JD, et al. Clin Dermatol. 2013 Nov-Dec;31(6):792-8. doi: 10.1016/j.clindermatol.2013.08.020. Clin Dermatol. 2013. PMID: 24160289 Review.
-
Treatment of skin malignancies.
Reynolds PL, Strayer SM. Reynolds PL, et al. J Fam Pract. 2003 Jun;52(6):456-64. J Fam Pract. 2003. PMID: 12791228 Review.
-
Nonsurgical treatment of nonmelanoma skin cancer in the mature patient.
Čeović R, Petković M, Mokos ZB, Kostović K. Čeović R, et al. Clin Dermatol. 2018 Mar-Apr;36(2):177-187. doi: 10.1016/j.clindermatol.2017.10.009. Epub 2017 Nov 3. Clin Dermatol. 2018. PMID: 29566922 Review.
-
Prager R, Khachemoune A. Prager R, et al. Dermatol Nurs. 2006 Dec;18(6):584-5. Dermatol Nurs. 2006. PMID: 17286161 No abstract available.
Cited by
-
Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.
Guenin-Macé L, Oldenburg R, Chrétien F, Demangel C. Guenin-Macé L, et al. Cell Mol Life Sci. 2014 Jul;71(13):2443-50. doi: 10.1007/s00018-014-1561-z. Epub 2014 Jan 21. Cell Mol Life Sci. 2014. PMID: 24445815 Free PMC article. Review.
-
Clinical practice trends in cryosurgery: a retrospective study of cutaneous lesions.
Afsar FS, Erkan CD, Karaca S. Afsar FS, et al. Postepy Dermatol Alergol. 2015 Apr;32(2):88-93. doi: 10.5114/pdia.2015.48048. Epub 2015 Mar 30. Postepy Dermatol Alergol. 2015. PMID: 26015777 Free PMC article.
-
Histopathological Features of the Eyelid Basal Cell Carcinomas.
MercuȚ IM, TĂnasie CA, Ilia LC, Simionescu C, Stepan A, Ciurea M, MercuȚ R. MercuȚ IM, et al. Curr Health Sci J. 2020 Apr-Jun;46(2):167-172. doi: 10.12865/CHSJ.46.02.10. Epub 2020 Jun 30. Curr Health Sci J. 2020. PMID: 32874689 Free PMC article.
-
Keah SH, Ng SC. Keah SH, et al. Malays Fam Physician. 2020 Nov 10;15(3):10-21. eCollection 2020. Malays Fam Physician. 2020. PMID: 33329859 Free PMC article. Review.
-
Antitumor Effect of Albendazole on Cutaneous Squamous Cell Carcinoma (SCC) Cells.
Zhang QL, Lian DD, Zhu MJ, Li XM, Lee JK, Yoon TJ, Lee JH, Jiang RH, Kim CD. Zhang QL, et al. Biomed Res Int. 2019 Jun 9;2019:3689517. doi: 10.1155/2019/3689517. eCollection 2019. Biomed Res Int. 2019. PMID: 31281836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical